Live Breaking News & Updates on Overall Clinical Lab Volume Trends April To

Share this article
Share this article
ResearchAndMarkets.com s offering.
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. The analyst has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the team on the fast-breaking events in the COVID-19 epidemic.
Particular sections address the most important market changes:
Molecular Diagnostics: COVID-19 has seen the molecular In Vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndrome tests, high throughput systems and surge production on badly needed kits. ....

United States , Beckman Coulter , Asia Pacific , Laura Wood , Koninklijke Philips , Vaccines In Development , Therapeutic Development , G Medical Innovations Holding Ltd , Research Lab Shutdown And Decline Status , Ascom Holding Ag , Cue Health , Research Antibodies , Custom Research , Life Science Research , Teladoc Health , Telehealth Company Responses , Becton Dickinson , Office Hours Call , Ascom Holding , Overall Clinical Lab Volume Trends April To , E St Office Hours Call , Research And Publications , Clinical Testing , Antibody Tests , Science Research , Patient Monitoring ,